WHO Official: ‘Excessive’ Non-Justified Trials Can Delay Access
This article was originally published in PharmAsia News
Executive Summary
Countries that insist on local clinical trial data for some already tested drugs and vaccines may be unnecessarily delaying access to potentially life-saving treatments, and might consider extensive pharmacovigilance as an alternative, a senior World Health Organization official tells an international conference in New Delhi.